Summary comparisons
| . | Marrow donors . | PBSC donors . | P value . |
|---|---|---|---|
| Physical status5-150 | 3.74 | 4.40 | .23 |
| Emotional status5-150 | 6.38 | 5.83 | .40 |
| Worst pain5-150 | 6.06 | 6.30 | .72 |
| Average pain5-150 | 5.09 | 4.53 | .37 |
| Pain duration5-150 | 7.09 | 6.53 | .46 |
| Pain interference with sleep5-150 | 5.06 | 5.33 | .74 |
| Words describing pain5-151 | 4.50 | 4.90 | .52 |
| Symptom burden5-152 | 1.90 | 1.76 | .18 |
| . | Marrow donors . | PBSC donors . | P value . |
|---|---|---|---|
| Physical status5-150 | 3.74 | 4.40 | .23 |
| Emotional status5-150 | 6.38 | 5.83 | .40 |
| Worst pain5-150 | 6.06 | 6.30 | .72 |
| Average pain5-150 | 5.09 | 4.53 | .37 |
| Pain duration5-150 | 7.09 | 6.53 | .46 |
| Pain interference with sleep5-150 | 5.06 | 5.33 | .74 |
| Words describing pain5-151 | 4.50 | 4.90 | .52 |
| Symptom burden5-152 | 1.90 | 1.76 | .18 |
Data show the average maximum for each item through the first 14 days after donation but also including the period of filgrastim administration for PBSC donors. The differences between the groups were tested separately for each end point by means of t tests for independent samples.
PBSC indicates peripheral blood stem cell.
This was rated on an 11-point scale of 0 (minimum) to 10 (maximum).
Data show the average number of words used.
The mean score for the 23 symptoms or adverse experiences measured on a 4-point scale.